Although PD-L1 was intrinsically expressed on B16F10 or MC38 tumor cells, SUP3 treatment did not enhance PD-L1 expression, not even on 4T1 tumor cells that were PD-L1-negative (Fig. 6D). The gene discussed is CD274; the disease is neoplasm.